JANE STREET GROUP, LLC - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYES and the CUSIP is 81362J209. A total of 31 filers reported holding SECOND SIGHT MED PRODS INC in Q1 2021. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q2 2022$44,000
+193.3%
21,601
+111.8%
0.00%
Q1 2022$15,000
-74.6%
10,198
-71.9%
0.00%
Q4 2021$59,000
-89.5%
36,299
-79.5%
0.00%
Q3 2021$564,000
-57.4%
177,118
-33.8%
0.00%
Q2 2021$1,323,000
+208.4%
267,573
+414.0%
0.00%
Q1 2021$429,000
+972.5%
52,059
+142.2%
0.00%
Q4 2020$40,00021,4920.00%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Altium Capital Management LP 373,867$1,847,0000.43%
NewGen Asset Management Ltd 200,000$988,0000.37%
SABBY MANAGEMENT, LLC 174,900$864,0000.12%
Kepos Capital LP 100,000$494,0000.04%
Hudson Bay Capital Management LP 380,404$1,879,0000.02%
Paloma Partners Management Co 139,081$687,0000.01%
Cutler Group LLC / CA 24,495$121,0000.01%
Cutler Group LLC / CA 35,000$36,0000.00%
Stratos Wealth Partners, LTD. 15,543$77,0000.00%
Lake Point Wealth Management 1,000$5,0000.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders